Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002443489 | SCV002683216 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-10-21 | criteria provided, single submitter | clinical testing | The c.946_961del16 pathogenic mutation, located in coding exon 6 of the MSH2 gene, results from a deletion of 16 nucleotides at nucleotide positions 946 to 961, causing a translational frameshift with a predicted alternate stop codon (p.S316Lfs*10). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |